Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 21, Issue 5-6, 1996, Pages 359-368

  Matherly, Larry H ^a,b   Taub, Jeffrey W ^a,b,c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Acute lymphoblastic leukemia; Chromosome 21; Hyperdiploidy; Methotrexate; Methotrexate polyglutamates

Indexed keywords

DIHYDROFOLATE REDUCTASE; METHOTREXATE; POLYGLUTAMIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CHROMOSOME 21; DRUG METABOLISM; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LEUKEMOGENESIS; LYMPHOBLAST; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029962417     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609093433     Document Type: Article

References (15)

1. Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F. and Wolff, V. A. (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl glutamic acid (aminopterin). N. Engl. J. Med., 238, 787-793.
2. Zuelzer, W. W. and Flatz, G. (1960) Acute childhood leukemia: a ten-year study. Am. J. Dis. Child., 100, 886-907.
3. Poplack, D. G. (1993) Acute lymphoblastic leukemia. In Principles and Practice of Pediatric Oncology, edited by P. A. Pizzo and D. G. Poplack, pp. 431-481. Philadelphia: J.B. Lippincott Co.
4. Pediatric Oncology Group. (1992) Progress against childhood cancer: The Pediatric Oncology Group experience. Pediatr., 89, 597-600.
5. Balis, F. M., Holcenberg, J. S. and Poplack, D. G. (1993) General principles of chemotherapy. In Principles and Practice of Pediatric Oncology, edited by P. A. Pizzo and D. G. Poplack, pp. 197-245. Philadelphia: J. B. Lippincott Co.
6. Goldman, I. D. and Matherly, L. H. (1985) The cellular pharmacology of methotrexate. Pharmacol. Ther., 28, 77-100.
7. Matherly, L. H. (1995) Mechanisms of receptor-mediated folate and antifolate membrane transport in cancer chemotherapy. In Drug Transport in Antimicrobial and Anticancer Chemotherapy, edited by N. H. Georgopapadakou, pp. 453-524. New York: Marcel Dekker, Inc.
8. Sirotnak, F. M. (1985) Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport: biological significance and implications of improved therapy of human cancer. Cancer Res., 45, 3992-4000.
9. Matherly, L. H., Czajkowski, C. A. and Angeles, S. M. (1991) Identification of a highly glycosylated methotrexate membrane carrier in K562 erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res., 51, 3420-3426.
10. Freisheim, J. H., Ratnam, M., McAlinden, T. P., Prasad, K. M. R., Williams, F. E., Westerhof, G. R., Schornagel, J. H. and Jansen, G. (1992) Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines. Adv. Enzyme Regul, 32, 17-31.
11. Dixon, K. H., Lampher, B. C., Chiu, J., Kelley, K. and Cowan, K. H. (1994) A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport-deficient cells. J. Biol. Chem., 269, 17-20.
12. Williams, F. M. R., Murray, R. C., Underbill, T. M. and Flintoff, W. F. (1994) Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J. Biol. Chem., 269, 5810-5816.
13. Prasad, P. D., Ramamoorthy, S., Leibach, F. H. and Ganapathy, V. (1995) Molecular cloning of the human placental folate transporter. Biochem. Biophys. Res. Commun., 206, 681-687.
14. Williams, F. M. N. and Flintoff, W. F. (1995) Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J. Biol. Chem., 270, 2087-2092.
15. Wong, S. C., Proefke, S. A., Bhushan, A. and Matherly, L. H. (1995) Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport defective Chinese hamster ovary cells. J. Biol. Chem., 270, 17468-17475.